Skinny Labels, Big Savings Act
Official title: A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on the Judiciary.
Skinny Labels, Big Savings Act
This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.
Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.
The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:
- submitting or seeking approval of a skinny label for a generic or biosimilar drug;
- promoting or commercially marketing a drug with skinny labeling approved by the FDA; or
- describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.
The bill also applies the safe harbor to similar actions under the Public Health Service Act.
- Introduced in Senate Formatted Text PDF Formatted XML
- SANOFI US SERVICES INC.
- BIOTECHNOLOGY INNOVATION ORGANIZATION
- RADIUS ADVOCACY, LLC
- WILEY REIN LLP
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
- GSK (FKA GLAXOSMITHKLINE INC.)
Bodies those filers lobbied
- SENATE
- HOUSE OF REPRESENTATIVES
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Office of Management & Budget (OMB)
- U.S. Trade Representative (USTR)
- Patent & Trademark Office (PTO)
- Commerce, Dept of (DOC)
Cite this page
U.S. Congress. (2026). S. 43: Skinny Labels, Big Savings Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-43/
"S. 43: Skinny Labels, Big Savings Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-43/.
S. 43, 119th Cong. (2026), https://openamerica.io/bill/119-S-43/.
[S. 43: Skinny Labels, Big Savings Act](https://openamerica.io/bill/119-S-43/)